Home → Careers → Promising Gene Therapies Pose Million-Dollar Conundrum → Full Text
By Nature
June 15, 2016
![[article image]](https://cacm.acm.org/system/assets/0002/3993/61516.nature.sickle_cell_anemia.large.jpg?1476779505&1466011459 "Sickle cell anemia")
Drugs that act by modifying a patient’s genes are close to approval in the United States, and one is already available in Europe. The developments mark a triumph for the field of gene therapy, once considered controversial.
From Nature
View Full Article
No entries found
Create a Web Account
If you are an ACM member, Communications subscriber, Digital Library subscriber, or use your institution's subscription, please set up a web account to access premium content and site features. If you are a SIG member or member of the general public, you may set up a web account to comment on free articles and sign up for email alerts.